Granules India Limited Amino Export Data — India (DGFT 2022–2026)

Name: Granules India Limited Amino Export Records India — #1 Exporter, 1,700 Shipments, $85.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Amino

India Pharmaceutical Trade Intelligence

$322.7M635 Suppliers161 CountriesHS 30049099

ExportsIndia → UNITED STATES57.7%India → PHILIPPINES8.6%

ImportsAUSTRIA → India$824.0M PORTUGAL → India$518.4M

#1 Supplier: GRANULES INDIA #1 Buyer: GRANULES CONSUMER

Granules India Limited — Amino Exporter #1 | $85.0M Trade Value | TransData Nexus | TransData Nexus

Granules India Limited — Amino Exporter Profile

Indian Pharmaceutical Exporter · #1 for Amino · $85.0M export value · DGFT Verified

Granules India Limited is the #1 Indian exporter of Amino with $85.0M in export value and 1,700 verified shipments. Granules India Limited holds a 26.3% market share in Amino exports across 19 countries. The company exports 20 pharmaceutical products worth $412.3M across 9 therapeutic categories.

Granules India Limited — Amino Export Profile: Buyers & Destinations

Granules India Limited Amino export treemap — buyers and destination countries | TransData Nexus

Where Does Granules India Limited Export Amino?

Country	Value	Shipments	Share
UNITED STATES	$60.0M	1,522	88.8%
CANADA	$3.9M	87	5.8%
UNITED STATES OF AMERICA	$1.6M	34	2.4%
CHILE	$328.9K	8	0.5%
COLOMBIA

Who Are the Top Buyers of Amino from Granules India Limited?

Buyer	Country	Value	Orders
GRANULES CONSUMER HEALTH	UNITED STATES	$36.6M	926
GRANULES USA INC	UNITED STATES	$12.3M	316
GRANULES USA INC.	UNITED STATES	$9.9M	256
LABORATOIRE RIVA INC	CANADA	$2.0M	40
GRANULES CONSUMER HEALTH LLC	UNITED STATES	$1.1M	24
MARCAN PHARMACEUTICALS INC	CANADA	$969.2K	22
GRANULES CONSUMER HEALTH, LLC	UNITED STATES	$650.3K	14
PHARMASCIENCE INC.	CANADA	$350.0K	7
TEVA CANADA LIMITED	CANADA	$350.0K	7
SHANDEX SALES GROUP LIMITED	CANADA	$208.9K	10

Granules India Limited supplies Amino to 47 buyers globally. The largest buyer is GRANULES CONSUMER HEALTH (UNITED STATES), followed by GRANULES USA INC (UNITED STATES) and GRANULES USA INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Amino Formulations Does Granules India Limited Export?

Product Description / Formulation	Value	Shipments
ACETAMINOPHEN EXTENDED RELEASE TABLETS U	$7.4M	148
ACETAMINOPHEN RAPID RELEASE GELCAPS 500M	$1.9M	37
TYLENOL 8HR-ARTHRITIS PAIN-ACETAMINOPHENER TABLETS-650MG 225S	$1.8M	40
ACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MG	$1.6M	39
EXTRA STRENGTH ACETAMINOPHEN USP 500MG CAPLETS	$1.2M	33
ACETAMINOPHEN EXTENDED-RELEASE TABLETS U	$1.2M	26
ACETAMINOPHEN EXTENDED RELEASE TABLETS (	$1.0M	20
COMPRESSO PAP 90 CPC ACETAMINOPHEN DIRECTLY COMPRESSIBLE GRANULES	$800.0K	16
COMPRESSO PAP 90 CPC (ACETAMINOPHEN DIRECTLY COMPRESSIBLE GRANULES)	$525.4K	11
ACETAMINOPHEN 500MG AND DIPHENHYDRAMINE	$515.2K	17

Granules India Limited exports 801 distinct Amino formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ACETAMINOPHEN EXTENDED RELEASE TABLETS U with 148 shipments worth $7.4M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Granules India Limited Compare to Nearest Amino Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	GRANULES INDIA LIMITED ★	$85.0M	1,700	19	$50.0K
2	ELYSIUM PHARMACEUTICALS LTD	$19.6M	392	1	$50.0K
4	OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED	$14.0M	288	27	$48.5K

Granules India Limited ranks #1 among 635 Indian Amino exporters. Average shipment value of $50.0K compared to the market average of $280.2K. The closest competitors by value are ELYSIUM PHARMACEUTICALS LTD and OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED.

Which Indian Ports Ship Amino Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	739	8.2%
HYDERABAD ICD	698	7.8%
SAHAR AIR CARGO ACC (INBOM4)	633	7.0%
HYDERABAD ICD (INSNF6)	574	6.4%
SAHAR AIR	548	6.1%
JNPT/ NHAVA SHEVA SEA	418	4.6%
MUNDRA SEA	417	4.6%
MUNDRA SEA (INMUN1)	364	4.0%

Geopolitical & Trade Policy Impact on Granules India Limited's Amino Exports

Granules India's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, compelling maritime carriers to reroute via the Cape of Good Hope. This has resulted in increased lead times and freight costs, posing challenges for time-sensitive pharmaceutical shipments. To mitigate these risks, Granules India is leveraging its multi-site manufacturing capabilities and strategic inventory positioning. (pharmaceuticalcommerce.com)

The U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters like Granules India, as global buyers seek to diversify their supply chains. However, compliance with evolving U.S. pharmaceutical import policies remains crucial. In the European Union, the implementation of the Falsified Medicines Directive necessitates stringent serialization and traceability measures. Granules India's proactive approach to regulatory compliance positions it favorably to navigate these complexities and maintain its export momentum.

Granules India Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Granules India, given its extensive export operations. The company's Gagillapur facility in Telangana received a warning letter from the U.S. Food and Drug Administration (FDA) in February 2025, following an inspection that identified issues related to equipment maintenance and contamination control. In response, Granules India implemented comprehensive corrective and preventive actions, including engaging independent consultants and enhancing cleaning protocols. The company has been providing regular updates to the FDA and is prepared for re-inspection to demonstrate compliance. (moneycontrol.com)

Conversely, Granules India's U.S.-based packaging facility in Virginia successfully cleared an FDA inspection in December 2025 with zero observations, reflecting the company's commitment to quality and regulatory excellence. (pharma.economictimes.indiatimes.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Amino shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Granules India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,700 individual customs records matching Granules India Limited exporting Amino, covering 801 formulations to 21 countries via 47 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 161+ countries, 1,400+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Amino

Amino

Granules India Limited — Amino Exporter Profile

Granules India Limited — Amino Export Profile: Buyers & Destinations

Where Does Granules India Limited Export Amino?

Who Are the Top Buyers of Amino from Granules India Limited?

What Is India's Total Amino Export Value and How Much Does Granules India Limited Contribute?

What Is the Average Shipment Value for Granules India Limited's Amino Exports?

How Does Granules India Limited Compare to Other Indian Amino Exporters?

What Amino Formulations Does Granules India Limited Export?

Regulatory Requirements: Exporting Amino to Key Markets

United States — FDA

Canada — HC

How Does Granules India Limited Compare to Nearest Amino Exporters?

Which Indian Ports Ship Amino Exports?

What Other Nutritional Supplements Products Does Granules India Limited Export?

Amino — Export Intelligence Video

Geopolitical & Trade Policy Impact on Granules India Limited's Amino Exports

Granules India Limited — Regulatory Compliance & Quality Standards

About Granules India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Amino Export Data from Granules India Limited

Amino Stats

Company Overview

Top Products by Granules India Limited

Related Analysis

Need Detailed Export Data?

Data Source